Back to Awarded Treatment Trials
Awarded Trial: 13T-010
Grant ID
13T-010
Illness
schizophrenia and bipolar disorder
Primary Drug/Intervention
GNbAC1
Primary Dosage
6 mg/kg
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Cancelled
Investigator
Leboyer
Sample Size
30
Duration of Study Period for Each Subject
176 days
Outcome Measurements
N/A
Results
Study was cancelled because of inability to obtain the drug.
Publication
N/A
Link
N/A
PI Name
Marion Leboyer
Degree
MD
Center
Psychiatric Sercie of the Creteil University Hospital
Institution
Chenevier-Mondor Hospital
Address
40 rue de Mesly
City or Town
Creteil
State or Province
N/A
Zip or Postal Code
94000
Country
France
Email Address
contact@geneuro.com